Table 1.
Baseline characteristics of 12 kidney transplant (KT) recipients with chronic hepatitis C (CHC) who received antiviral therapy with direct acting antivirals (DAAs)

Baseline characteristics of 12 kidney transplant (KT) recipients with chronic hepatitis C (CHC) who received antiviral therapy with direct acting antivirals (DAAs)
